Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.36 USD | +1.24% | -2.02% | -29.57% |
Financials (USD)
Sales 2024 * | 279M | Sales 2025 * | 322M | Capitalization | 601M |
---|---|---|---|---|---|
Net income 2024 * | -69M | Net income 2025 * | -58M | EV / Sales 2024 * | -0.71 x |
Net cash position 2024 * | 800M | Net cash position 2025 * | 755M | EV / Sales 2025 * | -0.48 x |
P/E ratio 2024 * |
-8.71
x | P/E ratio 2025 * |
-10.7
x | Employees | 1,184 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.71% |
Latest transcript on Fulgent Genetics, Inc.
1 day | +0.10% | ||
1 week | -4.56% | ||
Current month | -7.33% | ||
1 month | -7.46% | ||
3 months | -23.01% | ||
6 months | -20.17% | ||
Current year | -30.44% |
Managers | Title | Age | Since |
---|---|---|---|
Ming Hsieh
CEO | Chief Executive Officer | 68 | 16-05-12 |
James Xie
FOU | Founder | 58 | 16-05-12 |
Paul Kim
DFI | Director of Finance/CFO | 56 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ming Hsieh
CEO | Chief Executive Officer | 68 | 16-05-12 |
Linda Marsh
BRD | Director/Board Member | 74 | 19-07-31 |
Regina Groves
BRD | Director/Board Member | 66 | 23-01-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.30% | 27 M€ | -7.00% | - | |
0.26% | 29 M€ | -6.85% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 20.36 | +1.24% | 156 226 |
24-04-18 | 20.11 | +0.10% | 219,603 |
24-04-17 | 20.09 | -3.04% | 221,621 |
24-04-16 | 20.72 | -0.14% | 157,558 |
24-04-15 | 20.75 | -0.14% | 190,824 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.44% | 601M | |
-18.11% | 8.02B | |
+36.93% | 3.51B | |
-26.72% | 2.97B | |
-8.06% | 2.48B | |
-14.04% | 2.23B | |
-14.89% | 1.76B | |
-23.12% | 1.44B | |
-39.19% | 1.25B | |
-11.20% | 1.11B |
- Stock Market
- Equities
- FLGT Stock